Aphria Inc. to Be Shoppers Drug Mart’s Cannabis Supplier: Time to Buy Loblaw Companies Ltd.?

Aphria Inc. (TSX:APH) won a supply deal with Loblaw Companies Ltd. (TSX:L) under the condition that it receives approval from Health Canada. Here’s what investors need to know.

| More on:

Aphria Inc. (TSX:APH) announced plans to become a supplier of medical cannabis to Loblaw Companies Ltd.’s (TSX:L) Shoppers Drug Mart. Assuming Health Canada gives Shoppers Drug Mart the green light, cannabis could be available to Canadians through an online platform, since regulations still prevent the drugstore chain from selling the product at its brick-and-mortar locations. This is a huge positive development for Aphria and a gigantic leap for Loblaw, which will likely start selling cannabis in its stores some time following legalization day assuming all goes well.

Back in April, I’d stated that Loblaw was a safe way to play the legalization of cannabis for investors who didn’t have the stomachs for highly speculative cannabis stocks. Shoppers Drug Mart has been aggressively pushing to sell medical cannabis for quite some time now, and the recently announced supplier agreement is just the first step to becoming a major cannabis distributor in the legalization era.

Shoppers Drug Mart: A medical cannabis dispenser in the near term and a recreational dispenser in the long term?

I believe regulators will eventually become more flexible in time. A few years down the road, Shoppers Drug Mart could be a quick and convenient way for both medical and recreational users to obtain cannabis.

As of right now, “recreational has not been part of it,” said Vic Neufeld, Aphria CEO, when highlighting discussions of the recent supply agreement. Shoppers Drug Mart is a pharmacy chain first and foremost, so the cannabis being dispensed will be for medical purposes, at least until after legalization day.

“…pharmacies can, and should, play an important role in the safe and secure distribution of medical cannabis in Canada,” said Neufeld “[The deal] gives Aphria a huge, huge lift when it comes to shareholder value.”

Of course, Shoppers Drug Mart has become a lot more than just a pharmacy chain since being scooped up by Loblaw. It’s as much a convenience store as a drugstore today, so it’s likely that recreational users will also contribute to a huge chunk of overall cannabis sales at some point down the road.

Another promising candidate looking to land a cannabis-distribution licence

It’s not just Shoppers Drug Mart that’s hungry to sell weed. Alimentation Couche Tard Inc. (TSX:ATD.B), an incredibly efficient convenience store giant, is another promising candidate that could be dispensing recreational cannabis at its locations in a few years.

Couche Tard doesn’t sell “behind-the-counter” pharmaceuticals, so obtaining a distribution licence probably won’t be possible until sometime after legalization day. I believe regulators gradually become more open to alternative means of cannabis distribution, so Couche Tard is another potential legal cannabis beneficiary that investors should add to their radars.

Bottom line

Although Aphria signed the dotted line, it’s important to remember that Shoppers Drug Mart isn’t yet a licensed cannabis distributor. If Health Canada rejects its application, the deal goes out the window, and we probably won’t see cannabis being dispensed at pharmacy locations until regulations are gradually loosened over time.

I wouldn’t buy Loblaw just because of its subsidiary’s potential to sell cannabis. For this tailwind, there are many other headwinds to worry about, so it’s important to do your homework before pulling the trigger on Loblaw stock.

Stay hungry. Stay Foolish.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Joey Frenette owns shares of Alimentation Couche Tard Inc. Alimentation Couche Tard Inc. is a recommendation of Stock Advisor Canada.

More on Investing

Canadian dollars are printed
Dividend Stocks

Beat the TSX With This Cash-Gushing Dividend Stock

Toronto-Dominion Bank (TSX:TD) stock could do well in the year ahead.

Read more »

monthly desk calendar
Dividend Stocks

Monthly Income: Top Dividend Stocks to Buy in November

Here are two of the best monthly dividend stocks in Canada you can buy in November 2024 and hold for…

Read more »

hand stacks coins
Investing

A Top TSX Stock to Buy Now for Real Wealth Later

Intact Financial (TSX:IFC) stock is a fantastic dividend-growth play for the next 15 years and beyond.

Read more »

tsx today
Stock Market

TSX Today: What to Watch for in Stocks on Thursday, November 14

The U.S. wholesale inflation data and Fed chair Jerome Powell’s remarks about the economy will remain on TSX investors’ radar…

Read more »

Man data analyze
Tech Stocks

3 Reasons Celestica Stock Is a Screaming Buy Now

These three reasons make Celestica stock a screaming buy for long-term investors.

Read more »

profit rises over time
Dividend Stocks

These 2 Dow Stocks Are Set to Soar in 2025 and Beyond

Two Dow Jones stocks are screaming buys but Canadians must hold them in an RRSP or RRIF to avoid paying…

Read more »

TFSA (Tax free savings account) acronym on wooden cubes on the background of stacks of coins
Dividend Stocks

How to Use Your TFSA to Earn Ultimate Passive Income

If you have a TFSA, then you have the key to creating ultimate passive income. All you need is a…

Read more »

Confused person shrugging
Dividend Stocks

Better Buy: Fortis Stock or Hydro One Stock?

Let's do a compare and contrast of these two top utilities stocks right now, shall we?

Read more »